A Review on Epilepsy and its Management
Today, people face various types of stress in everyday fast life and most people in the world suffer from various neurological disorder. Epilepsy is one of the most common neurological disorders of the brain, affecting about 50 million people around the world, and 90% of them are coming from developing countries. Genetic factors and brain infection, stroke, tumors and epilepsy cause high fever. It imposes a great economic burden on the health systems of countries associated with stigma and discrimination against the patient and also his family in the community, in the workplace, school and home. Many patients with epilepsy suffer from severe emotional stress, behavioral disorders and extreme social isolation. There are many different types of seizure and mechanisms by which the brain generates seizures. The two features of generating seizures are hyperexcitability of neurons and a hyper synchronousneural circuits. A variety of mechanisms alters the balance between excitation and inhibition in predisposing brain local or generalized hyperexcitability region and a hypersynchronia. Purpose of the review is to discuss the history, epidemiology, etiology, pathophysiology, classification of epilepsy, symtomps, diagnosis, management of epilepsy and future trends.
Keywords: Anti-epileptic drugs, pathophysiology, seizures, epidemiology, hypersynchrony
2. Epilepsy: aetiogy (Sic), epidemiology and prognosis, World Health organization. 2001; Achieved form the original on 2007-05-18. Available at: http://web.archieve.org/web/20070518073641/http://www.who.int/mediacentre/facsheets/fs165/en/Retrieved 2007-06-14.
3.Commission on Epidemiology and prognosis. International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993; 34(4):592-96.
4. Blume W, Luders H, Mizrahi E, Tassinary C, Van Emde Boas W, Enjel J. Glossary of descriptive terminology for ictal semiology; report of the ILAE taskforce on classification and terminology. Epilepsia 2001; 42(9):1212-18.
5.Gregory L H, Yehezkiel Ben-A. The Neurobiology and Consequences of Epilepsy in the Developing Brain. Pediatric Research2001; 49(3):320-25.
6. Gidal BE, Garnett WR. Epilepsy. In: Dipiro J T, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. USA: McGraw-Hill Companies Inc, 6th ed. 2005:1023-46.
7. Fisher RS, Van Emde B, Blume W et al. Epileptic seizures and epilepsy: definition proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46(4):470-72.
8. Epilepsy: A Manual for Physicians. Word Health Organization. New Delhi: Regional Office for South-East Asia, 2004:1
9.The National Society for Epilepsy. what is epilepsy? 2009. Available at: http: //www.epilepsynse.org.kk/ about epilepsy/what is epilepsy (Accessed on 15 February 2009)
10.Cascino GD. Epilepsy: contemporary perspectives on evaluation and treatment. Mayo Clinic Proceedings 1994; 69:1199-11.
11.Engel J. Jr. Surgery for seizures. New England Journal of Medicine1996; 334(10): 647-652. Available at: doi: 10, 1056/NEJM199603073341008.PMID 8592530.
12. McNamara J O. Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE, Goodman Gilman A, 10th ed. Goodman and Gilman's the pharmacological basis of therapeutics. NewYork: McGraw-Hill Companies Inc, 2001: 521-48.
13. Oxford English Dictionary. Retrieved 8 September 2009.
14. Jilek-Aall L. Morbus Sacer in Africa; some religious aspects ofepilepsy in traditional cultures. Epilepsia 1999; 40(3):382-86.
15. Rho JM, Sankar R, Cavazos. JE. Epilepsy: Scientific foundations of clinical practice. New York: Marcel Dekker, 2004.
16. Hertz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhury AR, Zalutsky R. How common are the 'Common' neurologic disorders Neurology 2007; 68 (5):326-37.
17. Sridharan R. Epidemiology of epilepsy. Current Science2002; 82(6):664-70.
18. Hanna NJ, Black M, Sander J W et al. The national sentinel audit of epilepsy related death. The Stationary Office, London. 2002:1-135.
19. Marieb EN. Human anatomy and physiology. New Delhi Pearson Education Inc and Dorling Kindersley Publishing Inc, 6th ed. 2006:430-88.
20. Frucht MM, Quigg M, Schwaner C, Fountain NB. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000; 41(12):1534-39.
21. Herzog AG, Harden CL, Liporace J, Pennell P, Schomer DL, SperlingM. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Annals Neurology 2004; 56(3):431-34.
22. Lowenstein DH. Seizures and epilepsy. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, 16th ed Vol. 2. Harrison's principles of internal medicine. USA: McGraw-Hill Companies Inc, 2005:2357-72.
23. Meisler MH, Kearney JA. Sodium channel mutations in epilepsy and other neurological disorders. Journal of Clinical Investigation 2005; 115(8):2010-17
24.Commission on classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489-01.
25. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30:389-99.
26. Porter RJ, Meldrum BS. Antiseizure drugs. In: Katzung BG, ed. Basic and clinical pharmacology. New York: Mc Graw-Hill Companies Inc, 10th edition. 2006: 378.
27. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. New Delhi: Churchill Livingstone Reed Elsevier India (P) Ltd, 5th ed. 2006:550-60.
28. Tripathi KD. Essential of medical pharmacology. New Delhi: Jaypee Brothers Medical publishers (P) Ltd, 5th ed. 2003:369-80.
29. Guyton AC, Hall JE. Text book of medical physiology.; Elsevier a division of Reed Elsevier India (P) Ltd, 11th ed. 2007:743-47.
30. Sweetman S C. Martindale the complete drug reference. London: Pharmaceutical Press, 33rd ed. 2002:338-69.
31.Wolf P of Cabbages and kings: Some consideration on classifications, diagnostic schemes, semiology and concepts. Epilepsia. 2003; 44(1): 1-4.
32.Block JH, Beale JM. Wilson and Gisvold's text book of organic medicinal and pharmaceutical chemistry. 11th ed. Lippincott Williams and Wilkins, 2010:503.
33.Bennett PN, Brown MJ. Clinical pharmacology. New Delhi: Elsevier a division of Reed Elsevier India (P) Ltd, 9th ed. 2006: 413-22.
34.Rall TW, Schleifer LS. Drugs effective in the therapy of the epilepsies. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F, eds. Goodman & Gilman's the pharmacological basis of therapeutics. New York: Macmillan Publishing Company, 7th ed. 1985: 446-72.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).